Company profile
Grupo International Inc.
OTC: GRPI · Healthcare · Medical - Pharmaceuticals
PublicReports USD
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 7
v0.1 · 5/100 weight · pillars only
↑ disclosure history, Piotroski F · ↓ balance-sheet leverage, market scale
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$55.6k
Employees
—
as of 2026-08-31
Market cap
$1.0k
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02010
Net income-$55.6k-$55.6k2010
Operating income-$55.6k-$55.6k2010
Total assets$5.5k$5.5k2010
Liabilities$438.4k$438.4k2010
Equity-$432.8k-$432.8k2010
Revenue trend
FY2003 – FY2010 · USD
FY03
FY04
FY05
FY06
FY07
FY08
FY09
FY10
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Grupo International Inc.’s revenue?
Grupo International Inc. booked $0 in FY2010 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Imagin Medical Inc.——CVR Medical Corp.——Lynx Global Digital Finance Corporation——Omnimmune Holdings, Inc.——TetraLogic Pharmaceuticals Corporation——BioELife Corp.——Key facts
CEORamon Richard Mora
SectorHealthcare
IndustryMedical - Pharmaceuticals
Headquarters—
ExchangeOTC: GRPI
Employees—
IPO date2023-05-23
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.